Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse AGRP ELISA Kit (AC3038)
Cat.#: ASET-1627
Specifications
Description Mouse AGRP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse AGRP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.53 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1680 Rat Insulin Receptor beta ELISA Kit (AC3091) Quantitative inquiry ASET-2479 Rat ASRGL1 ELISA Kit (AC3890) Quantitative inquiry ASET-2523 Mouse SOCS2 ELISA Kit (AC3934) Quantitative inquiry ASET-1262 Human PACAP ELISA Kit (AC2673) Quantitative inquiry ASET-1305 Human beta Synuclein ELISA Kit (AC2716) Quantitative inquiry ASET-1991 Human SLC25A12 ELISA Kit (AC3402) Quantitative inquiry ASET-1984 Mouse PGP9.5 ELISA Kit (AC3395) Quantitative inquiry ASET-2116 Mouse NG2 ELISA Kit (AC3527) Quantitative inquiry ASET-1469 Mouse Choline Acetyltransferase ELISA Kit (AC2880) Quantitative inquiry ASET-1639 Human Ataxin 1 ELISA Kit (AC3050) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket